JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Details Textual) - USD ($)			1 Months Ended				3 Months Ended	9 Months Ended		12 Months Ended	62 Months Ended
	Aug. 11, 2017	Aug. 03, 2012	Aug. 31, 2017	Aug. 25, 2016	Jun. 01, 2016	Mar. 31, 2016	Sep. 30, 2017	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Sep. 30, 2017	Jul. 14, 2017	Aug. 31, 2016
Related Party Transaction [Line Items]
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures		$ 6,000,000					$ 6,000,000	$ 6,000,000			$ 6,000,000	$ 1,000,000
Joint Venture Investments In Voting Common Ownership Units (in shares)		600,000
Joint Venture Investments In Non Voting Preferred Ownership Units		5,000,000
Development Activities Monthly Fee		$ 63,000
Joint Venture, Operating Expenses, Inter Company Transactions								843,000			9,315,000
Joint Venture, Operating Expenses Allocated To Company								843,000			7,702,000
Percentage Of Non Royalty Income				5.00%
Conversion of Stock, Shares Converted	3,500,000					1,500,000
Conversion of Stock, Shares Issued						120,000
Joint Venture Method Investment Ownership Percentage		60.00%		62.20%
Proceeds from Issuance of Preferred Stock and Preference Stock								0	$ 946,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				33,088
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 10.70
Management Fees					$ 80,000
Professional Fees					$ 10,000
Accrued Professional Fees			$ 20,000
Conversion of Stock, Amount Converted	$ 3,500,000
Conversion of Stock, Amount Issued	$ 1,000,000
Interest Payable												$ 79,000
Other Assets, Current							84,000	84,000		$ 131,000	84,000
Series B2 Preferred Stock [Member]
Related Party Transaction [Line Items]
Joint Venture Losses Recognition Criteria, Common Ownership Equity				$ 946,000									$ 946,000
Proceeds From Issuance Of Preferred Stock Before Adjusted Stock Issuance Costs				1,012,000
Proceeds from Issuance of Preferred Stock and Preference Stock				946,000
Conversion of Stock, Amount Issued				$ 1,000,000
Stock Issued During Period, Shares, Acquisitions	93,458			93,458
Stock Issued During Period, Value, Acquisitions	$ 1,000,000
Series B1 And B2 Preferred Stock [Member]
Related Party Transaction [Line Items]
Joint Venture Method Investment Ownership Percentage		62.20%
Series B1 Preferred Stock [Member]
Related Party Transaction [Line Items]
Joint Venture Losses Recognition Criteria, Common Ownership Equity				$ 946,000
Proceeds From Issuance Of Preferred Stock Before Adjusted Stock Issuance Costs				1,012,000
Proceeds from Issuance of Preferred Stock and Preference Stock				946,000						946,000
Payments of Stock Issuance Costs				$ 66,000
Stock Issued During Period, Shares, New Issues				94,537
Management Fees			$ 300,000							300,000
Professional Fees										60,000
Management Fee Expense							150,000			250,000
Other Commitment, Due in Second Year							150,000	150,000			150,000
Accrued Professional Fees							40,000	40,000			40,000
Other Assets, Current										$ 50,000
Revolving Credit Facility [Member]
Related Party Transaction [Line Items]
Long-term Line of Credit							1,620,000	1,620,000			1,620,000
Interest Payable							20,000	20,000			20,000
Common Stock [Member]
Related Party Transaction [Line Items]
Joint Venture Losses Recognition Criteria, Common Ownership Equity							$ 0	$ 0			$ 0
Preferred Stock [Member]
Related Party Transaction [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent							100.00%	100.00%			100.00%
Noncontrolling Interest [Member]
Related Party Transaction [Line Items]
Noncash or Part Noncash Acquisition, Other Liabilities Assumed											$ 667,000
Maximum [Member]
Related Party Transaction [Line Items]
Joint Venture Method Investment Ownership Percentage						64.00%
Minimum [Member]
Related Party Transaction [Line Items]
Joint Venture Method Investment Ownership Percentage						60.00%
Exclusive License Agreement [Member]
Related Party Transaction [Line Items]
Percentage Of Royalty Payment				3.00%
Annual Maintenance Payments				$ 25,000
Exclusive License Agreement [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Milestone Payments				500,000
Royalty Expense				1,000,000
Exclusive License Agreement [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Milestone Payments				50,000
Royalty Expense				$ 500,000
Lipimetix [Member]
Related Party Transaction [Line Items]
Joint Venture Investments Common Ownership Units, Co-venture (in shares)		400,000
Ownership Percentage Co-venture		40.00%
Noncash or Part Noncash Acquisition, Other Liabilities Assumed								$ 667,000
Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)		$ 378,000						$ 378,000
Equity Method Investment, Ownership Percentage							64.00%	64.00%			64.00%
Lipimetix [Member] | Ownership As Converted [Member]
Related Party Transaction [Line Items]
Equity Method Investment, Ownership Percentage		69.75%					69.75%	69.75%			69.75%
Voting Common Ownership Units [Member]
Related Party Transaction [Line Items]
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures		$ 1,000,000
Non Voting Preferred Ownership Units [Member]
Related Party Transaction [Line Items]
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures		$ 5,000,000